Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize tumor killing effect of an anti-VISTA monoclonal antibody in tumor bearing mice

被引：1
|
作者：
Jiang, Xiling
Leu, Jocelyn
Singh, Indrajeet
Snyder, Linda A.
Wang, Weirong
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2085
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2085
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Anti-tumor effect of internal image bearing anti-idiotypic monoclonal antibody in relation to GM3 ganglioside
    Jinnohara, T
    Tsujisaki, M
    Sasaki, S
    Hinoda, Y
    Taniguchi, M
    Imai, K
    INTERNATIONAL JOURNAL OF CANCER, 1998, 76 (03) : 345 - 353
  • [32] Anti-Tumor Effect of Steamed Codonopsis lanceolata in H22 Tumor-Bearing Mice and Its Possible Mechanism
    Li, Wei
    Xu, Qi
    He, Yu-Fang
    Liu, Ying
    Yang, Shu-Bao
    Wang, Zi
    Zhang, Jing
    Zhao, Li-Chun
    NUTRIENTS, 2015, 7 (10): : 8294 - 8307
  • [33] Pharmacokinetic/pharmacodynamic modeling of etoposide tumor growth inhibitory effect in Walker-256 tumor-bearing rat model using free intratumoral drug concentrations
    Pigatto, Maiara Cassia
    Roman, Renatha Menti
    Carrara, Letizia
    Buffon, Andreia
    Magni, Paolo
    Dalla Costa, Teresa
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 97 : 70 - 78
  • [34] Investigation of the mechanism of aflibercept mediated modulation of doxorubicin anti-tumor effects in a preclinical model of leukemia: Development of a pharmacokinetic-pharmacodynamic model to guide combination dosing strategies
    Telang, Urvi
    Lal, Deepika
    Zagst, Patricia D.
    Fetterly, Gerald J.
    Wang, Eunice S.
    CANCER RESEARCH, 2010, 70
  • [35] MECHANISM OF DECREASING LIVER UPTAKE OF IN-111-LABELED ANTICARCINOEMBRYONIC ANTIGEN MONOCLONAL-ANTIBODY BY SPECIFIC ANTIBODY PRETREATMENT IN TUMOR-BEARING MICE
    BEATTY, BG
    OCONNERTRESSEL, M
    DO, TL
    PAXTON, RJ
    BEATTY, JD
    CANCER RESEARCH, 1990, 50 (03) : S846 - S851
  • [36] EVALUATION OF L6, AN ANTI-CARCINOMA MURINE MONOCLONAL-ANTIBODY, IN TUMOR-BEARING NUDE-MICE
    LAVIE, E
    BEAUMIER, PL
    BRODZINSKY, L
    HELLSTROM, KE
    HELLSTROM, I
    RADIOTHERAPY AND ONCOLOGY, 1989, 15 (03) : 295 - 305
  • [37] Development of a whole body physiologically-based pharmacokinetic (PBPK) model with individualized tumor compartment for topotecan (TPT) in mice bearing neuroblastoma (NB)
    Patel, Yogesh T.
    Jacus, Megan O.
    Shirinifard, Abbas
    Davis, Abigail D.
    Thiagarajan, Suresh
    Throm, Stacy L.
    Daryani, Vinay M.
    Sablauer, Andras
    Stewart, Clinton F.
    CANCER RESEARCH, 2015, 75
  • [38] BIODISTRIBUTION OF MONOCLONAL-ANTIBODY PO66 IN A HUMAN LUNG TUMOR-BEARING MOUSE MODEL - EFFECT OF BLOOD-EXCHANGE ON TUMOR-ANTIBODY UPTAKE
    DESRUES, B
    QUINQUENEL, ML
    TOUJAS, L
    DELAVAL, P
    DAZORD, L
    NUCLEAR MEDICINE AND BIOLOGY, 1995, 22 (05): : 569 - 572
  • [39] Chronopharmacodynamics of gefitinib-based anti-cancer effect in Lewis tumor-bearing mice
    Zhang, Bin
    Cheng, Yanqin
    Fang, Xiujie
    Lu, Qing
    Liu, Jiao
    Liu, Guoxin
    Wang, Peipei
    Liu, Liang
    Lin, Pingping
    Li, Mingchun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (08): : 15414 - 15425
  • [40] Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide to Characterize Its Antiobesity Effects in Diet-Induced Obese Mice
    Iwasaki, Shinji
    Hamada, Teruki
    Chisaki, Ikumi
    Andou, Tomohiro
    Sano, Noriyasu
    Furuta, Atsutoshi
    Amano, Nobuyuki
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 362 (03): : 441 - 449
12345